Edition:
United Kingdom

People: Lannett Company Inc (LCI.N)

LCI.N on New York Stock Exchange

5.68USD
25 Jun 2019
Change (% chg)

$0.04 (+0.71%)
Prev Close
$5.64
Open
$5.71
Day's High
$5.80
Day's Low
$5.52
Volume
220,643
Avg. Vol
281,009
52-wk High
$14.65
52-wk Low
$3.34

Galvan, Martin 

Mr. Martin P. Galvan, CPA, is no longer Chief Financial Officer, Vice President - Finance, Treasurer of the Company, effective August 30, 2019. Most recently, he was Chief Financial Officer of CardioNet, Inc., a medical technology and service company. From 2001 to 2007, Mr. Galvan was employed by Viasys Healthcare Inc., a healthcare technology company that was acquired by Cardinal Health, Inc. in June 2007. Prior to the acquisition, he served as Executive Vice President, Chief Financial Officer and Director Investor Relations. From 1999 to 2001, Mr. Galvan served as Chief Financial Officer of Rodel, Inc., a precision surface technologies company in the semiconductor industry. From 1979 to 1998, Mr. Galvan held several positions with Rhone-Poulenc Rorer Inc., a pharmaceutical company, including Vice President, Finance — The Americas; President & General Manager, RPR Mexico & Central America; Vice President, Finance, Europe/Asia Pacific; and Chief Financial Officer, United Kingdom & Ireland. Mr. Galvan began his career with the international accounting firm Ernst & Young LLP. He earned a Bachelor of Arts degree in economics from Rutgers University and is a member of the American Institute of Certified Public Accountants.

Basic Compensation

Total Annual Compensation, USD 415,000
Restricted Stock Award, USD 207,505
Long-Term Incentive Plans, USD --
All Other, USD 141,240
Fiscal Year Total, USD 763,745

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Patrick LePore

129,785

Timothy Crew

1,329,780

Martin Galvan

763,745

John Abt

565,013

Maureen Cavanaugh

--

Grant Brock

--
As Of  30 Jun 2018